{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:50:13Z","timestamp":1758441013357,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.medcli.2022.09.010","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T07:25:49Z","timestamp":1671434749000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Papel actual de las t\u00e9cnicas de imagen en la amiloidosis card\u00edaca"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-7690","authenticated-orcid":false,"given":"Michal","family":"Pudis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorka","family":"Bastarrika Alema\u00f1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2022.09.010_bib0260","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2022.09.010_bib0265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/16.11.673","article-title":"X-ray diffraction studies on amyloid filaments","volume":"16","author":"Eanes","year":"1968","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.medcli.2022.09.010_bib0270","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","article-title":"Cardiac amyloidosis: Pathology, nomenclature, and typing","volume":"24","author":"Maleszewski","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.medcli.2022.09.010_bib0280","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2022.09.010_bib0285","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coph.2005.10.005","article-title":"Systemic amyloidosis","volume":"6","author":"Lachmann","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0290","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2018.05.018","article-title":"Therapies for cardiac light chain amyloidosis: An update","volume":"271","author":"Aimo","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0295","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0300","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2022.09.010_bib0305","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.medcli.2022.09.010_bib0310","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2022.09.010_bib0315","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.hlc.2019.11.019","article-title":"Amyloid Cardiomyopathy","volume":"29","author":"Bart","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.medcli.2022.09.010_bib0320","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2022.09.010_bib0325","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2022.09.010_bib0330","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11886-019-1180-2","article-title":"Cardiac Amyloidosis: Updates in Imaging","volume":"21","author":"Chacko","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.medcli.2022.09.010_bib0335","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS - The Transthyretin Amyloidosis Outcomes Survey: Initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"Coelho","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.medcli.2022.09.010_bib0340","first-page":"845","article-title":"Fabry cardiomyopathy: Parametric mapping adds even more","volume":"75","author":"Ruiz Pizarro","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.medcli.2022.09.010_bib0345","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis Prognosis, and Therapy of Transthyretin Amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0350","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0355","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9149(82)90270-3","article-title":"Amyloid cardiomyopathy: Characterization by a distinctive voltage\/mass relation","volume":"49","author":"Carroll","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0360","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2022.09.010_bib0365","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/anec.12036","article-title":"Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis","volume":"18","author":"Mussinelli","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0370","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","article-title":"Prognostic implication of relative regional strain ratio in cardiac amyloidosis","volume":"102","author":"Senapati","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2022.09.010_bib0375","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0380","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2022.09.010_bib0385","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0390","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2022.09.010_bib0395","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","article-title":"Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis","volume":"2","author":"Austin","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0400","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"13","author":"Fontana","year":"2015","journal-title":"Circulation."},{"issue":"Suppl 1.","key":"10.1016\/j.medcli.2022.09.010_bib0405","first-page":"78","article-title":"Miocardiopat\u00edas infiltrativas Aporte de la resonancia cardiaca","volume":"26","author":"Claudia","year":"2019","journal-title":"Rev Colomb Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0410","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jcmg.2016.02.035","article-title":"Staging Cardiac Amyloidosis With CMR: Understanding the Different Phenotypes","volume":"9","author":"Fontana","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0420","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.012506","article-title":"Cardiac Magnetic Resonance-Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid","author":"Chacko","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0425","doi-asserted-by":"crossref","first-page":"355.e15","DOI":"10.1016\/j.amjmed.2005.08.043","article-title":"Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis","volume":"119","author":"Hazenberg","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.medcli.2022.09.010_bib0430","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/CIRCIMAGING.111.967836","article-title":"Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping","volume":"5","author":"Thavendiranathan","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0435","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/RTI.0000000000000077","article-title":"Myocardial tissue characterization by magnetic resonance imaging: Novel applications of T1 and T2 mapping","volume":"29","author":"Ferreira","year":"2014","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0440","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial Edema and Prognosis in Amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0445","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0002-9149(83)80140-4","article-title":"Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis","volume":"51","author":"Falk","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0450","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0455","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0460","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2022.09.010_bib0465","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaccas.2021.02.016","article-title":"Hereditary Apolipoprotein A-I-Associated Cardiac Amyloidosis: Importance of Endomyocardial Biopsy When Suspicion Remains High","volume":"3","author":"Saleem","year":"2021","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.medcli.2022.09.010_bib0470","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.medcli.2022.09.010_bib0475","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0480","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: A pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0485","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","article-title":"Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: More than hearts and minds","volume":"45","author":"Wagner","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0490","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A Routine PET\/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front Cardiovasc Med"},{"issue":"Supp1","key":"10.1016\/j.medcli.2022.09.010_bib0495","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13506129.2017.1281120","article-title":"Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: A pilot study","volume":"24","author":"Law","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.medcli.2022.09.010_bib0500","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12350-018-1365-x","article-title":"Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.medcli.2022.09.010_bib0505","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain Transthyretin Amyloidosis, and Mimicking Conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2022.09.010_bib0510","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","article-title":"Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging","volume":"45","author":"Ezawa","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322005309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322005309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:56:04Z","timestamp":1758419764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775322005309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0025775322005309"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2022.09.010","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papel actual de las t\u00e9cnicas de imagen en la amiloidosis card\u00edaca","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2022.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}